Importantly, in the EAE model, AhR activation can modulate CNS autoimmunity in divergent directions in a ligand-specific fashion, with FICZ exacerbating disease and TCDD and tryptamine ameliorating disease [124–126]. This evidence concerns the gene AHR and Autoimmunity.